Teva Pharmaceutical Industries Limited (FRA:TEV)
Germany flag Germany · Delayed Price · Currency is EUR
13.45
-0.65 (-4.61%)
Last updated: Aug 1, 2025

Teva Pharmaceutical Industries Company Description

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products.

The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies.

The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin’s lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders – chorea associated with Huntington’s disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder.

The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names.

It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH.

The company was founded in 1901 and is based in Tel Aviv, Israel.

Teva Pharmaceutical Industries Limited
CountryIsrael
Founded1901
IndustryPharmaceutical Preparations
Employees35,686
CEORichard Francis

Contact Details

Address:
124 Dvora HaNevi’a St.
Tel Aviv, 6944020
Israel
Phone972 3 914 8213
Websitetevapharm.com

Stock Details

Ticker SymbolTEV
ExchangeFrankfurt Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code2834

Key Executives

NamePosition
Richard FrancisChief Executive Officer
Eliyahu KalifChief Financial Officer
Matthew ShieldsChief Operating Officer
Christopher StevoHead of Investor Relations